Screening behavior in women at increased familial risk for breast cancer

scientific article published on 07 July 2006

Screening behavior in women at increased familial risk for breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1039361841
P356DOI10.1007/S10689-006-0006-8
P698PubMed publication ID16817030

P50authorKelly-Anne PhillipsQ41368487
John ReynoldsQ47095546
P2093author name stringShirley S Wong
Yoland C Antill
Katherine M Tucker
Tracy E Dudding
Juliana L Di Iulio
Judy A Kirk
Mary Anne Young
Tarli L Bogtstra
P2860cites workAttitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancerQ73031582
Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testingQ73210569
Breast cancer screening uptake in women at increased risk of developing hereditary breast cancerQ73806394
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testingQ74008289
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancerQ74299619
Screening adherence in BRCA1/2 families is associated with primary physicians' behaviorQ75382688
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeQ77565294
Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancerQ80603464
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesQ24531993
Systematic review of management options for women with a hereditary predisposition to ovarian cancerQ30761251
Earlier detection of breast cancer by surveillance of women at familial riskQ33179978
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial riskQ33181647
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionQ33205307
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies ConsortiumQ34064381
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceQ34480599
The epidemiology of ovarian cancerQ34521875
Fear, anxiety, worry, and breast cancer screening behavior: a critical reviewQ35739340
Perception of risk in women with a family history of breast cancerQ35976086
Prevention and management of hereditary breast cancerQ36065462
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohortQ36696244
Impact of Event Scale: A Measure of Subjective StressQ39513124
Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.Q39680986
Adherence and psychological adjustment among women at high risk for breast cancerQ40747928
Family history of breast cancer and screening behavior: An inverted U-shaped curve?Q41150441
The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?Q44696476
Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.Q47244223
Validity of women's self-reports of cancer screening test utilization in a managed care population.Q47346513
Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.Q50692482
Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.Q50708880
Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer.Q50748111
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.Q50748795
Early detection of breast and ovarian cancer in families with BRCA mutations.Q50757471
Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.Q51059520
Psychological Distress and Surveillance Behaviors of Women With a Family History of Breast CancerQ51153527
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.Q52123195
Early detection of familial ovarian cancer.Q52891983
Guidelines for the management of women at increased familial risk of breast cancer.Q53291917
Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart auditQ57758936
Mammography use among sociodemographically diverse women: the accuracy of self-reportQ71158528
P433issue4
P304page(s)359-368
P577publication date2006-07-07
P1433published inFamilial CancerQ15761917
P1476titleScreening behavior in women at increased familial risk for breast cancer
P478volume5

Reverse relations

cites work (P2860)
Q33576648A cross-sectional survey assessing factors associated with reading cancer screening information: previous screening behaviour, demographics and decision-making style
Q35231571Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry
Q33653466Association between cancer risk perception and screening behavior among diverse women
Q51275648Association between cancer screening behavior and family history among Japanese women.
Q37219731Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)
Q37590233Components of family history associated with women's disease perceptions for cancer: a report from the Family Healthware™ Impact Trial
Q45924134Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.
Q34944244Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes
Q37404594Ethical issues of predictive genetic testing for diabetes
Q34707733Healthcare use after screening for lung cancer
Q34102513Intermittent attendance at breast cancer screening
Q37471829Patient compliance based on genetic medicine: a literature review.
Q51973142Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling.
Q35527940Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer
Q43554932The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer

Search more.